Enrollment

REBETOL®
(ribavirin)
CRIXIVAN®
(indinavir sulfate)
ISENTRESS®
(raltegravir)
GARDASIL®
[Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]
JANUVIA®
(sitagliptin phosphate)
JANUMET®
(sitagliptin/metformin HCl)
MAXALT®
(rizatriptan benzoate)
SINGULAIR®
(montelukast sodium)
VARICELLA ZOSTER VIRUS-CONTAINING VACCINES


Enrollment

Health care professionals are encouraged to report any instances of prenatal exposure to a Registry product as early in pregnancy as possible by calling the Merck Pregnancy Registry at 1-800-986-8999 or by downloading and completing the attached forms and faxing them to the registry.

Criteria for enrollment include:

  1. Report of pregnancy from a patient or health care provider
  2. Exposure to a Merck product during pregnancy (or, in the case of a vaccine, within 1-3 months prior to conception)
  3. Name of health care provider (to confirm diagnoses and to obtain outcome information)
  4. Name of patient or, if you wish to keep the report confidential, patient initials and one other patient identifier, like date of birth or chart number, to allow for follow-up at expected date of delivery

Information from the Registry is used to respond to inquiries from health care providers who call to request information on the use of a product during pregnancy. Data may be published or used to update the pregnancy section of the product label as appropriate. Dissemination of data collected in the Registry is done without compromising individual patient confidentiality. Information from the Registry is shared, as required, with regulatory authorities (e.g., FDA).

We encourage health care providers to report cases of exposure during pregnancy as early in the pregnancy as possible to facilitate the collection of prospective, unbiased information.

Annual reports from the Pregnancy Registry contain up-to-date information on product exposure during pregnancy and can be requested by health care providers by calling 1-800-986-8999 or by downloading the attached Annual Report Request form and faxing the completed form to the Registry at 267-305-6541.

 

 


CRIXIVAN  |  GARDASIL  |  ISENTRESS  |  JANUVIA  |  JANUMET  |  MAXALT  |  PROQUAD  |  REBETOL  |  SINGULAIR  |  VARIVAX  |  ZOSTAVAX  | 
Enrollment  |  Home  |  Privacy Policy

Copyright 2012 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.